These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26100370)

  • 21. Risk for the development of non-alcoholic fatty liver disease: A prospective study.
    Wang J; Ma L; Chen S; Xu L; Miao M; Yu C; Li Y; Xu C
    J Gastroenterol Hepatol; 2018 Aug; 33(8):1518-1523. PubMed ID: 29381226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary sodium and potassium intake in relation to non-alcoholic fatty liver disease.
    Choi Y; Lee JE; Chang Y; Kim MK; Sung E; Shin H; Ryu S
    Br J Nutr; 2016 Oct; 116(8):1447-1456. PubMed ID: 27725000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population.
    Lee SW; Lee TY; Yang SS; Tung CF; Yeh HZ; Chang CS
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):45-48. PubMed ID: 29428103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Importance of sugar and sugar substitutes].
    Verspohl EJ
    Med Monatsschr Pharm; 2014 May; 37(5):191-2. PubMed ID: 24908939
    [No Abstract]   [Full Text] [Related]  

  • 25. Sugary beverages represent a threat to global health.
    Popkin BM
    Trends Endocrinol Metab; 2012 Dec; 23(12):591-3. PubMed ID: 22867870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beverage consumption and paediatric NAFLD.
    Mosca A; Della Corte C; Sartorelli MR; Ferretti F; Nicita F; Vania A; Nobili V
    Eat Weight Disord; 2016 Dec; 21(4):581-588. PubMed ID: 27565159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re: soda and other beverages and the risk of kidney stones.
    Assimos DG
    J Urol; 2014 Feb; 191(2):381. PubMed ID: 24411862
    [No Abstract]   [Full Text] [Related]  

  • 28. Orange juice vs soft drinks.
    Alçada MN; Monteiro R; Calhau C; Azevedo I
    Arch Intern Med; 2009 Feb; 169(3):315. PubMed ID: 19204227
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
    Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
    BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association or causation of sugar-sweetened beverages and coronary heart disease: recalling Sir Austin Bradford Hill.
    Huffman MD
    Circulation; 2012 Apr; 125(14):1718-20. PubMed ID: 22412071
    [No Abstract]   [Full Text] [Related]  

  • 31. Reducing Intake of Sugar-Sweetened Beverages Is Vital to Improving Our Nation's Health.
    Johnson RK
    Circulation; 2016 Jan; 133(4):347-9. PubMed ID: 26755504
    [No Abstract]   [Full Text] [Related]  

  • 32. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preventing heart failure: sweetened beverages and healthy lifestyles.
    Martínez-González MA; Ruiz-Canela M
    Heart; 2015 Dec; 101(24):1935-7. PubMed ID: 26526419
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors.
    Prasetya IB; Hasan I; Wisnu W; Rumende CM
    Acta Med Indones; 2017 Apr; 49(2):91-98. PubMed ID: 28790222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Your CE topic this month (No. 29). An update on natural and artificial sweeteners.
    D'Angelo AC
    J Pract Nurs; 1988 Mar; 38(1):20-7. PubMed ID: 3351767
    [No Abstract]   [Full Text] [Related]  

  • 36. Sugar free medicines--are you using them?
    Johnston DI
    Arch Dis Child; 1986 Mar; 61(3):216-7. PubMed ID: 3963864
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
    Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
    World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A model to predict the onset of non-alcoholic fatty liver disease within 2 years in elderly adults.
    Lin YJ; Gao XM; Pan WW; Gao S; Yu ZZ; Xu P; Fan XP
    J Gastroenterol Hepatol; 2017 Oct; 32(10):1739-1745. PubMed ID: 28183156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracy of a noninvasive hepatic ultrasound score for non-alcoholic fatty liver disease (NAFLD) in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
    Goulart AC; Oliveira IR; Alencar AP; Santos MS; Santos IS; Martines BM; Meireles DP; Martines JA; Misciagna G; Benseñor IM; Lotufo PA
    Sao Paulo Med J; 2015; 133(2):115-24. PubMed ID: 26018881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of sitting time and physical activity with non-alcoholic fatty liver disease.
    Ryu S; Chang Y; Jung HS; Yun KE; Kwon MJ; Choi Y; Kim CW; Cho J; Suh BS; Cho YK; Chung EC; Shin H; Kim YS
    J Hepatol; 2015 Nov; 63(5):1229-37. PubMed ID: 26385766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.